Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation... see more

OTCPK:GBGPF - Post Discussion

GB Group Ord Shs > Updated revenue per dried gram: $9.71
View:
Post by Fearspect on Mar 17, 2017 11:51am

Updated revenue per dried gram: $9.71

Still pretty good though. https://finance.yahoo.com/news/cannimed-therapeutics-inc-corrects-previously-135100002.html
Comment by The6Kid on Mar 17, 2017 12:21pm
Pretty shady to overstate it by 11%... or sloppy to allow it to get into the realeased fins. 
Comment by AntonChigurh on Mar 17, 2017 1:18pm
Nothing is shady about CMED, but I agree it is sloppy. After releasing the previous quarters financials a day late, and now another error, I'm not pleased with whoever is in charge of the finances. CMED has a stellar rep and doesn't need to be compromised with silly accounting errors or people not being able to meet deadlines. I emailed IR to see what their response is about how this ...more  
Comment by thorgb1 on Mar 20, 2017 3:59pm
CMED needs to shape up. Absolutely embarrassing to put out a restatement on a key piece of data from the financials. IMHO, this is the best MMJ stock on the market, but I question if current management has the ability to run the company as a listed entity rather then a private co. We definitely should not be 1/4 the market cap of Canopy at this point. 
Comment by AntonChigurh on Mar 21, 2017 12:09am
Were 1/6 of the MC of Canopy, not 1/4, which is even more of a JOKE.  Here is the IR reply to my e-mail: 'Hi XXXXX,    Pertaining to your question regarding the recent Q1 financials:   A typo resulted in two incorrect selling prices being quoted in the MD&A and also in one place in the news release.  Although there was no effect on the financial statements or ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities